Reuters logo
BRIEF-ANI Pharmaceuticals reports Q4 loss per share $0.09
March 2, 2017 / 1:49 PM / in 8 months

BRIEF-ANI Pharmaceuticals reports Q4 loss per share $0.09

March 2 (Reuters) - ANI Pharmaceuticals Inc:

* Q4 adjusted non-gaap earnings per share $0.84

* Ani pharmaceuticals reports full year 2016 results and fourth quarter results and provides 2017 guidance

* Q4 loss per share $0.09

* Q4 revenue rose 112 percent to $38.2 million

* Ani pharmaceuticals inc sees 2017 adjusted non-gaap ebitda of $73.1 million to $77.2 million

* Ani pharmaceuticals inc sees 2017 new adjusted non-gaap diluted earnings per share methodology yielding $3.58 to $3.94 per share

* Ani pharmaceuticals inc says forecasting approximately $40 to $45 million in operating cash flow in 2017

* Ani pharmaceuticals inc says expect to invest upwards of $11 million in capital expenditures in 2017

* Fy2017 earnings per share view $4.44 -- Thomson Reuters I/B/E/S Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below